logo
logo

Glubio Pharmaceutical Raises $50M Series A

Feb 28, 2022over 3 years ago

Amount Raised

$50 Million

Round Type

series a

Description

GluBio Pharmaceutical has secured nearly $50 million in a Series A round of financing, bringing the total capital raised by the drugmaker to $70 million, it said in a statement on Monday.

Company Information

Company

Glu Bio Pharmaceutical

About

Proceeds from the financing will be used for tapping pipeline candidates, platform upgradation, and talent acquisition, the company said.

FundzWatch™ Score

65
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech